UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000030812
Receipt number R000035180
Scientific Title Efficacy of Lyophilized Human Prothrombin Complex Concentrate on acute patients with hemorrhage: a single arm phase II study
Date of disclosure of the study information 2018/01/15
Last modified on 2021/01/17 17:36:06

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Efficacy of Lyophilized Human Prothrombin Complex Concentrate on acute patients with hemorrhage: a single arm phase II study

Acronym

Lyophilized Human Prothrombin Complex Concentrate on acute patients: a single arm phase II study

Scientific Title

Efficacy of Lyophilized Human Prothrombin Complex Concentrate on acute patients with hemorrhage: a single arm phase II study

Scientific Title:Acronym

Lyophilized Human Prothrombin Complex Concentrate on acute patients: a single arm phase II study

Region

Japan


Condition

Condition

Severe trauma patients with cerebral hemorrhage, those who were admitted to the Advanced Critical Care and Emergency Center and had less than 2 in PT-INR

Classification by specialty

Neurosurgery Emergency medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate an efficacy of Lyophilized Human Prothrombin Complex Concentrate

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Changes in hemorrhage between the beginning of medication and hospital discharge

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

1) Once during a hospital stay
2) Amount
PT-INR >=2, <4: body weight<=100kg = 25IU/kg, body weight>100kg = 2500IU
PT-INR >=4, <=6: body weight<=100kg = 35IU/kg, body weight>100kg = 3500IU
PT-INR >6: body weight<=100kg = 50IU/kg, body weight>100kg = 5000IU

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Severe trauma patients with cerebral hemorrhage, those who were admitted to the Advanced Critical Care and Emergency Center and had less than 2 in PT-INR

Key exclusion criteria

1) Severe trauma patients with cerebral hemorrhage, those who were admitted to the Advanced Critical Care and Emergency Center and had greater than or equal to 2 in PT-INR
2) Patients, those who were determined by a physician as not-adequate to include the study

Target sample size

10


Research contact person

Name of lead principal investigator

1st name Ichiro
Middle name
Last name Takeuchi

Organization

Yokohama City University Medical Center

Division name

Advanced Critical Care and Emergency Center

Zip code

232-0024

Address

4-57 Urafunecho, Minamiku, Yokohama, Kanagawa

TEL

045-261-5656

Email

itake@myad.jp


Public contact

Name of contact person

1st name Takashi
Middle name
Last name Kawasaki

Organization

Yokohama City University Medical Center

Division name

Advanced Critical Care and Emergency Center

Zip code

232-0024

Address

4-57 Urafunecho, Minamiku, Yokohama, Kanagawa

TEL

045-261-5656

Homepage URL


Email

tks59jn@gmail.com


Sponsor or person

Institute

Yokohama City University

Institute

Department

Personal name



Funding Source

Organization

Self funding

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Advanced Critical Care and Emergency Center, Yokohama City University Medical Center

Address

4-57 Urafunecho, Minamiku, Yokohama City, Kanagawa

Tel

045-261-5656

Email

takeru-a@umin.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 01 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

0

Results

Continuing patient recruiting

Results date posted

2020 Year 01 Month 17 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2018 Year 01 Month 01 Day

Date of IRB

2017 Year 06 Month 01 Day

Anticipated trial start date

2018 Year 01 Month 01 Day

Last follow-up date

2021 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2018 Year 01 Month 15 Day

Last modified on

2021 Year 01 Month 17 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000035180


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name